Ann-July Ellenrieder

EDUCATION

College / University

Georg-August Universität Göttingen

Highest Degree

Bachelor of Science

Major Subjects

Molecular Medicine

Ellenrieder_1

Country

Germany

Lab Experience

Cell culture, DNA/RNA isolation, real time PCR, gene expression, gel electrophoresis, protein analysis via SDS-PAGE and Western Blot, yeast cloning techniques and genetics, native PAGE, activity assay, fluorescence microscopy, MitoTracker assay, nanoparticle extraction

Projects / Research

  • 2024: Bachelor thesis “Regulation of yeast proteasomes by shifts in carbon source” (supervised by Prof. Mark Hochstrasser, Yale University)
  • 2023: Research internship “Investigation of proteasome activity across metabolic states in yeast” (Group of Prof. Mark Hochstrasser, Yale University)
  • 2023: Methods internship at the University Medical Center Göttingen in the diagnostic of neurodegenerative diseases (Lab of Prof. Zerr)
  • 2023: Research internship “Characterization of a HEK-MYC-KO cell line” (Group of Prof. Wulf, stem cell therapy and stem cell transplantation, University Medical Center Göttingen)
  • 2019: Methods internship at the National Institute of Health (NIH) in „cancer genomics“ (Lab of Prof. Ried)

Scholarships / Awards

2024 – 2025: Stipend by the International Max Planck Research School
since 2021: e-fellows.net scholarship
2021: MINT-EC-certificate
2021: “Gesellschaft Deutscher Chemiker (GDCh)-Preis” (German Chemical Society Prize)
2021: “Deutsche Physikalische Gesellschaft (DPG) Abiturpreis” (German Physical Society Graduates-Prize)
2021: Excellence Award, in recognition of personal commitment, dedication and performance

SCIENTIFIC INTERESTS AND GOALS

My research projects have sparked a strong passion for understanding complex intracellular processes. From my research experience, I maintain the opinion that studying fundamental sciences, such as deciphering the workings and control of the proteasome, is as vital to medical progress as direct medical research, such as investigating MYC's role in leukemia and lymphoma development. I am particularly fascinated by protein degradation pathways, specifically the interplay between cellular metabolism and protein degradation pathways. This research captivates me because it has significant implications across numerous domains, including oncology and neuroscience. By bridging fundamental science and medical research, it will significantly enhance our understanding of these processes and potentially contribute to the treatment of various diseases.